Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera

Area of Science:

• Immunology
• Microbiology
• Complement System

Background:

• Chlamydial infections pose significant public health challenges.
• Immunoglobulin G (IgG) in human serum has shown potential in neutralizing Chlamydia.
• The role of the complement system in this neutralization is not fully understood.

Purpose of the Study:

• To investigate the role of human serum complement in the neutralization of Chlamydia infectivity by IgG.
• To determine which complement components are essential for IgG-mediated Chlamydia neutralization.
• To explore the effect of complement activation on antichlamydial IgG activity.

Main Methods:

• In vitro assays using human serum with varying complement component levels (intact, C5-depleted, C8-depleted).
• Heat inactivation of early complement components to assess their contribution.
• Addition of cobra venom factor (CVF) as a C3b analog to evaluate its impact on neutralization.
• Measurement of Chlamydia infectivity reduction in the presence of different serum conditions and antichlamydial IgG.

Main Results:

• Human serum IgG effectively neutralizes Chlamydia infectivity in vitro.
• Complement-intact, C5-depleted, and C8-depleted human sera exhibited significantly higher neutralizing activity compared to heat-inactivated serum.
• Cobra venom factor enhanced the neutralizing activity of antichlamydial IgG, even when early complement components were absent.

Conclusions:

• The human complement system, particularly components beyond the early ones, plays a critical role in IgG-mediated neutralization of Chlamydia.
• Early complement components are important for optimal IgG neutralization of Chlamydia.
• C3b or its analogs can enhance antichlamydial IgG activity, suggesting a mechanism for complement-dependent neutralization.